Stockscreener 앱 받기
17.99
2.97%
-0.55
전일 마감가:
$18.54
열려 있는:
$18.68
하루 거래량:
134.34K
Relative Volume:
0.41
시가총액:
$615.48M
수익:
-
순이익/손실:
$-81.05M
주가수익비율:
-6.858
EPS:
-2.6232
순현금흐름:
$-68.97M
1주 성능:
-3.59%
1개월 성능:
-11.51%
6개월 성능:
-31.05%
1년 성능:
-21.27%
1일 변동 폭
$17.84
$18.96
1주일 범위
$17.84
$19.74
52주 변동 폭
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
명칭
Arrivent Biopharma Inc
전화
240-780-6356
주소
18 CAMPUS BLVD., NEWTOWN SQUARE
AVBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
17.99 | 700.51M | 0 | -81.05M | -68.97M | -2.6232 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Buy |
| 2025-03-20 | 개시 | B. Riley Securities | Buy |
| 2025-03-10 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2024-02-20 | 개시 | Citigroup | Buy |
| 2024-02-20 | 개시 | Goldman | Buy |
| 2024-02-20 | 개시 | Jefferies | Buy |
모두보기
Arrivent Biopharma Inc 주식(AVBP)의 최신 뉴스
ArriVent BioPharma Inc. stock retracement – recovery analysisDaily Swing Candidate Analysis with Chart Patterns - Newser
What makes ArriVent BioPharma Inc. stock price move sharplyCapital Growth Summary Over Five Years - Newser
How to interpret RSI for ArriVent BioPharma Inc. stockFree Target Return Focused Trade Insights - Newser
Does ArriVent BioPharma Inc. fit your quant trading modelShort-Term Bounce Forecast for Oversold Stocks - Newser
Predicting ArriVent BioPharma Inc. trend using moving averagesCapital Protection Strategy With Risk Analysis - Newser
Lepu Biopharma Reports First-Ever Profit Amid Revenue Surge - TipRanks
ArriVent BioPharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWeekly Return Plan for Conservative Traders - Newser
Thermo Fisher to lay off 85 workers in San Diego County; Lepu Biopharma inks a deal - Endpoints News
How many analysts rate ArriVent BioPharma Inc. as a “Buy”Capitalize on high-growth stocks early - Jammu Links News
What is ArriVent BioPharma Inc. company’s growth strategyGet exclusive market insights for better trading - Jammu Links News
ArriVent BioPharma Inc. Stock Analysis and ForecastTrack high-yield stocks before they peak - Jammu Links News
How strong is ArriVent BioPharma Inc. company’s balance sheetMaximize gains with proven stock analysis - Jammu Links News
What is the risk reward ratio of investing in ArriVent BioPharma Inc. stockTake advantage of unprecedented market momentum - Jammu Links News
Why is ArriVent BioPharma Inc. stock attracting strong analyst attentionStay ahead with advanced stock screening tools - Jammu Links News
How volatile is ArriVent BioPharma Inc. stock compared to the marketDynamic growth stocks - Jammu Links News
Is ArriVent BioPharma Inc. stock overvalued or undervaluedCapitalize on fast-growing stocks today - Jammu Links News
What are ArriVent BioPharma Inc. company’s key revenue driversUnlock powerful market insights for success - Jammu Links News
How does ArriVent BioPharma Inc. compare to its industry peersUnlock exclusive stock market forecasts - Jammu Links News
Does ArriVent BioPharma Inc. stock perform well during market downturnsSuperior trading gains - Jammu Links News
When is ArriVent BioPharma Inc. stock expected to show significant growthBuild a winning portfolio with smart picks - Jammu Links News
How does ArriVent BioPharma Inc. generate profit in a changing economyFree Stock Market Knowledge Sharing - Jammu Links News
ArriVent BioPharma Inc. stock prediction for this weekAI Generated Buy/Sell Signal Forecast - Newser
Can you recover from losses in ArriVent BioPharma Inc.Free Real Trader Watchlist of Hot Stocks - Newser
Can trapped investors hope for a rebound in ArriVent BioPharma Inc.Predictive Short-Term Market Reversal Alerts - Newser
Using data models to predict ArriVent BioPharma Inc. stock movementFree Fundamental + Technical Hybrid Stock Tips - Newser
Quant Tools Rank ArriVent BioPharma Inc. as High Risk High RewardTrend Analysis for Safer Trades Gains Popularity - metal.it
Comparing ArriVent BioPharma Inc. in custom built stock radarsSmart Chart Forecasting with AI Algorithms - Newser
News impact scoring models applied to ArriVent BioPharma Inc.AI Short-Term Gain Forecast with Data - Newser
ArriVent BioPharma Inc. stock trend forecastBuy Signal System Based on Price Action - Newser
ArriVent BioPharma Inc. Earnings Report Breakdown: What Investors Should KnowMachine Learning Intraday Signal Forecast - Newser
Will ArriVent BioPharma Inc. price bounce be sustainableFree Entry and Exit Strategy Optimizer Tool - Newser
Sentiment analysis tools applied to ArriVent BioPharma Inc.Conservative Asset Allocation Risk Analysis - Newser
Tools to monitor ArriVent BioPharma Inc. recovery probabilityDaily Trade Setup Forecast with Confidence - Newser
Understanding ArriVent BioPharma Inc.’s price movementSecure Buy Strategy Based on Risk Parameters - Newser
Trend analysis for ArriVent BioPharma Inc. this weekStable Profit Zone and Loss Control Analysis - Newser
How ArriVent BioPharma Inc. stock performs during market volatilitySmart Trend Analysis With Buy Point Cues - Newser
Using RSI to spot recovery in ArriVent BioPharma Inc.Free Secure Capital Picks With Upside Potential - Newser
why arrivent biopharma inc. stock attracts strong analyst attentionBuy Point Strategy with Profit Protection - Newser
Arrivent Biopharma Inc (AVBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):